HSBC Holdings’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219K | Buy |
5,310
+222
| +4% | +$9.14K | ﹤0.01% | 2169 |
|
|
2025
Q1 | $255K | Buy |
5,088
+154
| +3% | +$7.7K | ﹤0.01% | 2037 |
|
|
2024
Q4 | $273K | Sell |
4,934
-1,525
| -24% | -$84.4K | ﹤0.01% | 2139 |
|
|
2024
Q3 | $214K | Sell |
6,459
-2,608
| -29% | -$86.4K | ﹤0.01% | 2193 |
|
|
2024
Q2 | $241K | Buy |
+9,067
| New | +$241K | ﹤0.01% | 2092 |
|
|
2023
Q4 | – | Sell |
-12,903
| Closed | -$217K | – | 2331 |
|
|
2023
Q3 | $217K | Sell |
12,903
-2,860
| -18% | -$48.1K | ﹤0.01% | 1886 |
|
|
2023
Q2 | $285K | Buy |
15,763
+4,141
| +36% | +$74.9K | ﹤0.01% | 1757 |
|
|
2023
Q1 | $149K | Buy |
+11,622
| New | +$149K | ﹤0.01% | 2017 |
|